+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viscosupplementation Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report

  • 100 Pages
  • August 2022
  • Region: Global
  • Infinium Global Research
  • ID: 5585056
The report on the global viscosupplementation market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global viscosupplementation market to grow with a CAGR of nearly 7% over the forecast period from 2022-2028. The study on viscosupplementation market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on viscosupplementation market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global viscosupplementation market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global viscosupplementation market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The growing spending on the research and innovations of viscosupplementation may
  • Growing collaborations among market players

2) Restraints

  • The lack of product penetration in underdeveloped nations

3) Opportunities

  • The increasing importance of the use of viscosupplementation treatment over sports injuries

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global viscosupplementation market is segmented on the basis of product, application, and end-use.

The Global Viscosupplementation Market by Product

  • Single Injection
  • Three Injections
  • Five Injections

The Global Viscosupplementation Market by Application

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis

The Global Viscosupplementation Market by End-use

  • Hospitals
  • Orthopedic Clinics/ASCs
  • Others

Company Profiles

The companies covered in the report include
  • Sanofi S.A.
  • Anika Therapeutics, Inc
  • Seikagaku Corporation
  • Zimmer Biomet
  • Smith & Nephew Plc
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Ferring B.V.
  • Chugai Pharmaceutical Co., Ltd
  • Bioventus

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the viscosupplementation market.
2. Complete coverage of all the segments in the viscosupplementation market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global viscosupplementation market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Viscosupplementation Market Highlights
2.2. Viscosupplementation Market Projection
2.3. Viscosupplementation Market Regional Highlights
3. Global Viscosupplementation Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Viscosupplementation Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Application
3.5.3. Growth Matrix Analysis by End-use
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Viscosupplementation Market
4. Viscosupplementation Market Macro Indicator Analysis
5. Global Viscosupplementation Market by Product
5.1. Single Injection
5.2. Three Injections
5.3. Five Injections
6. Global Viscosupplementation Market by Application
6.1. Knee Osteoarthritis
6.2. Hip Osteoarthritis
6.3. Hand Osteoarthritis
7. Global Viscosupplementation Market by End-use
7.1. Hospitals
7.2. Orthopedic Clinics/ASCs
7.3. Others
8. Global Viscosupplementation Market by Region 2022-2028
8.1. North America
8.1.1. North America Viscosupplementation Market by Product
8.1.2. North America Viscosupplementation Market by Application
8.1.3. North America Viscosupplementation Market by End-use
8.1.4. North America Viscosupplementation Market by Country
8.2. Europe
8.2.1. Europe Viscosupplementation Market by Product
8.2.2. Europe Viscosupplementation Market by Application
8.2.3. Europe Viscosupplementation Market by End-use
8.2.4. Europe Viscosupplementation Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Viscosupplementation Market by Product
8.3.2. Asia-Pacific Viscosupplementation Market by Application
8.3.3. Asia-Pacific Viscosupplementation Market by End-use
8.3.4. Asia-Pacific Viscosupplementation Market by Country
8.4. RoW
8.4.1. RoW Viscosupplementation Market by Product
8.4.2. RoW Viscosupplementation Market by Application
8.4.3. RoW Viscosupplementation Market by End-use
8.4.4. RoW Viscosupplementation Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Viscosupplementation Market
9.2. Companies Profiled
9.2.1. Sanofi S.A.
9.2.2. Anika Therapeutics, Inc
9.2.3. Seikagaku Corporation
9.2.4. Zimmer Biomet
9.2.5. Smith & Nephew Plc
9.2.6. LG Life Sciences Ltd
9.2.7. Lifecore Biomedical, LLC
9.2.8. Ferring B.V.
9.2.9. Chugai Pharmaceutical Co., Ltd
9.2.10. Bioventus

Companies Mentioned

  • Sanofi S.A.
  • Anika Therapeutics, Inc
  • Seikagaku Corporation
  • Zimmer Biomet
  • Smith & Nephew Plc
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Ferring B.V.
  • Chugai Pharmaceutical Co., Ltd
  • Bioventus